/Companies

Enzyre

Eindhoven, NL · 5 known investors

Find your way into Enzyre

Each arrow is one introduction. Sign up to fill in the first one.

6 people can intro you to Wim

Ask Jan Van den Berghe to introduce you to Wim van den Broek

You →Jan · together at Enzyre B.V. →Wim

Sign up to find every way you can get introduced to Enzyre

  • Your email: who you already know at Enzyre, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Enzyre team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care. The device aims to enable rapid therapy adjustment for patients and reduce healthcare costs by bringing laboratory testing capabilities to clinical settings.

Founders & leadership

WVWim van den Broek
Wim van den BroekCEOWim van den Broek is CEO of Enzyre, which develops a handheld diagnostic device for blood coagulation testing at the point of care. He has experience in general and financial management.
W
WaanderCSO

Investors · 5

Also in the syndicate · 1

Demcon Investment

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Enzyre do?
Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care. The device aims to enable rapid therapy adjustment for patients and reduce healthcare costs by bringing laboratory testing capabilities to clinical settings.
Who are Enzyre's investors?
Enzyre's investors include i&i Biotech Fund, Novalis Biotech, Oost NL, Takeda Ventures.
Where is Enzyre headquartered?
Enzyre is headquartered in Eindhoven, NL.